Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis. - Suppr | 超能文献

Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis.

作者信息

Ungheri D, Della Bruna C, Sanfilippo A

出版信息

G Ital Chemioter. 1984 Sep-Dec;31(3):211-4.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Activity of the spiropiperidyl rifamycin LM 427 on rifampicin resistant Mycobacterium tuberculosis.

G Ital Chemioter. 1984 Sep-Dec;31(3):211-4.

2

[Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare].[利福布汀（安莎霉素LM 427）对结核分枝杆菌、蟾分枝杆菌和鸟分枝杆菌-胞内分枝杆菌的最低抑菌浓度研究]

Rev Mal Respir. 1988;5(4):401-6.

3

[In vitro activities of rifabutine and rifampicin against various mycobacteria, especially Mycobacterium tuberculosis and Mycobacterium avium complex].利福布汀和利福平对各种分枝杆菌，尤其是结核分枝杆菌和鸟分枝杆菌复合群的体外活性

Kekkaku. 1988 Mar;63(3):167-72.

4

In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.鸟分枝杆菌复合群及结核分枝杆菌菌株对一种螺哌啶基利福霉素的体外敏感性

Am Rev Respir Dis. 1982 Sep;126(3):586-7. doi: 10.1164/arrd.1982.126.3.586.

5

In vitro activity of new rifamycins against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria.新型利福霉素对耐利福平结核分枝杆菌和MAIS复合群分枝杆菌的体外活性。

Tubercle. 1987 Sep;68(3):177-82. doi: 10.1016/0041-3879(87)90053-5.

6

Rifabutine: minimal inhibitory and bactericidal concentrations for Mycobacterium tuberculosis.利福布汀：结核分枝杆菌的最低抑菌浓度和杀菌浓度

Am Rev Respir Dis. 1988 Mar;137(3):719-21. doi: 10.1164/ajrccm/137.3.719.

7

The activity of rifabutin against Mycobacterium leprae.利福布汀对麻风分枝杆菌的活性。

Lepr Rev. 1991 Sep;62(3):280-7.

8

New rifabutin analogs: synthesis and biological activity against Mycobacterium tuberculosis.新型利福布汀类似物：抗结核分枝杆菌的合成及生物活性

Bioorg Med Chem Lett. 2006 Nov 15;16(22):5717-22. doi: 10.1016/j.bmcl.2006.08.090. Epub 2006 Sep 20.

9

Activity in vitro of rifabutin, FCE 22807, rifapentine, and rifampin against Mycobacterium microti and M. tuberculosis and their penetration into mouse peritoneal macrophages.利福布汀、FCE 22807、利福喷汀和利福平对田鼠分枝杆菌和结核分枝杆菌的体外活性及其对小鼠腹腔巨噬细胞的穿透能力。

Am Rev Respir Dis. 1992 Jan;145(1):212-4. doi: 10.1164/ajrccm/145.1.212.

10

Sensitivity to rifaximin and rifampicin of Mycobacterium tuberculosis isolated from guinea pigs treated orally with rifaximin.从经利福昔明口服治疗的豚鼠中分离出的结核分枝杆菌对利福昔明和利福平的敏感性。

Chemioterapia. 1987 Apr;6(2):82-4.

引用本文的文献

1

Rifabutin for treating pulmonary tuberculosis.利福布汀治疗肺结核。

Cochrane Database Syst Rev. 2007 Oct 17;2007(4):CD005159. doi: 10.1002/14651858.CD005159.pub2.

2

Rifabutin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.利福布汀。对其抗菌活性、药代动力学特性及治疗效果的综述。

Drugs. 1994 Jun;47(6):983-1009. doi: 10.2165/00003495-199447060-00008.

3

Absorption, disposition, and urinary metabolism of 14C-rifabutin in rats.大鼠体内14C-利福布汀的吸收、分布及尿液代谢情况

Antimicrob Agents Chemother. 1991 Jul;35(7):1391-6. doi: 10.1128/AAC.35.7.1391.